These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 6864436

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of beta- and gamma-cyclodextrins on the pharmacokinetic behavior of prednisolone after intravenous and intramuscular administrations to rabbits.
    Arimori K, Uekama K.
    J Pharmacobiodyn; 1987 Aug; 10(8):390-5. PubMed ID: 3694434
    [Abstract] [Full Text] [Related]

  • 5. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
    Miyake K, Arima H, Hirayama F, Yamamoto M, Horikawa T, Sumiyoshi H, Noda S, Uekama K.
    Pharm Dev Technol; 2000 Aug; 5(3):399-407. PubMed ID: 10934740
    [Abstract] [Full Text] [Related]

  • 6. [Enhanced bioavailability of acetohexamide by beta-cyclodextrin complexation (author's transl)].
    Uekama K, Matsuo N, Hirayama F, Ichibagase H, Arimori K, Tsubaki K, Satake K.
    Yakugaku Zasshi; 1980 Sep; 100(9):903-9. PubMed ID: 7218151
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhancement of oral bioavailability of spironolactone by beta- and gamma-cyclodextrin complexations.
    Seo H, Tsuruoka M, Hashimoto T, Fujinaga T, Otagiri M, Uekama K.
    Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):286-91. PubMed ID: 6850944
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Analysis of interfacial transfer and absorption behavior of drugs following dissolution from beta-cyclodextrin complexes.
    Uekama K, Uemura Y, Irie T, Otagiri M.
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3637-43. PubMed ID: 6671224
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protective mechanism of beta-cyclodextrin for the hemolysis induced with phenothiazine neuroleptics in vitro.
    Irie T, Sunada M, Otagiri M, Uekama K.
    J Pharmacobiodyn; 1983 Jun; 6(6):408-14. PubMed ID: 6138401
    [Abstract] [Full Text] [Related]

  • 15. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
    Arima H, Yunomae K, Hirayama F, Uekama K.
    J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Enhanced bioavailability of phenytoin by beta-cyclodextrin complexation (author's transl].
    Tsuruoka M, Hashimoto T, Seo H, Ichimasa S, Ueno O, Fujinaga T, Otagiri M, Uekama K.
    Yakugaku Zasshi; 1981 Apr; 101(4):360-7. PubMed ID: 7288580
    [No Abstract] [Full Text] [Related]

  • 18. Improvement of the oral bioavailability of digitalis glycosides by cyclodextrin complexation.
    Uekama K, Fujinaga T, Hirayama F, Otagiri M, Yamasaki M, Seo H, Hashimoto T, Tsuruoka M.
    J Pharm Sci; 1983 Nov; 72(11):1338-41. PubMed ID: 6644599
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.